Page last updated: 2024-10-25

cilostazol and Brain Diseases

cilostazol has been researched along with Brain Diseases in 1 studies

Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, W1
Liu, R1
Sun, W1
Peng, Q1
Zhang, W1
Xu, E1
Cheng, Y1
Ding, M1
Li, Y1
Hong, Z1
Wu, J1
Zeng, J1
Yao, C1
Huang, Y1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Cilostazol Stroke Prevention Study-a Randomized, Double Blind, Double Dummy, Parallel Comparative, Multicenter Clinical Trial[NCT00202020]Phase 3720 participants Interventional2004-05-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for cilostazol and Brain Diseases

ArticleYear
Different impacts of blood pressure variability on the progression of cerebral microbleeds and white matter lesions.
    Stroke, 2012, Volume: 43, Issue:11

    Topics: Aspirin; Blood Pressure; Brain; Brain Diseases; Cerebral Hemorrhage; Cilostazol; Disease Progression

2012